Goldman Sachs Group Inc Incyte Corp Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Incyte Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 873,470 shares of INCY stock, worth $62.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
873,470
Previous 948,736 7.93%
Holding current value
$62.1 Million
Previous $57.5 Million 0.39%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$57.33 - $68.61 $4.31 Million - $5.16 Million
-75,266 Reduced 7.93%
873,470 $57.7 Million
Q2 2024

Aug 13, 2024
BUY
$51.18 - $63.75 $11.5 Million - $14.3 Million
223,891 Added 30.89%
948,736 $57.5 Million
Q1 2024

May 15, 2024
SELL
$56.55 - $66.59 $25.7 Million - $30.2 Million
-453,681 Reduced 38.5%
724,845 $41.3 Million
Q4 2023

Feb 13, 2024
SELL
$52.16 - $64.19 $52 Million - $64 Million
-997,264 Reduced 45.83%
1,178,526 $74 Million
Q3 2023

May 14, 2024
BUY
$57.77 - $65.93 $57.6 Million - $65.7 Million
997,264 Added 84.62%
2,175,790 $126 Million
Q3 2023

Nov 14, 2023
SELL
$57.77 - $65.93 $29.7 Million - $33.9 Million
-513,915 Reduced 19.11%
2,175,790 $126 Million
Q2 2023

May 14, 2024
BUY
$60.95 - $75.51 $16.1 Million - $20 Million
264,515 Added 10.91%
2,689,705 $167 Million
Q2 2023

Aug 14, 2023
BUY
$60.95 - $75.51 $16.1 Million - $20 Million
264,515 Added 10.91%
2,689,705 $167 Million
Q1 2023

May 14, 2024
BUY
$70.23 - $86.01 $48.8 Million - $59.8 Million
694,757 Added 40.15%
2,425,190 $175 Million
Q1 2023

May 11, 2023
BUY
$70.23 - $86.01 $48.8 Million - $59.8 Million
694,757 Added 40.15%
2,425,190 $175 Million
Q4 2022

May 14, 2024
BUY
$67.18 - $84.11 $17.6 Million - $22.1 Million
262,424 Added 17.88%
1,730,433 $139 Million
Q4 2022

Feb 13, 2023
BUY
$67.18 - $84.11 $17.6 Million - $22.1 Million
262,424 Added 17.88%
1,730,433 $139 Million
Q3 2022

May 14, 2024
BUY
$66.18 - $82.86 $21.4 Million - $26.8 Million
323,019 Added 28.21%
1,468,009 $97.8 Million
Q3 2022

Nov 10, 2022
BUY
$66.18 - $82.86 $21.4 Million - $26.8 Million
323,019 Added 28.21%
1,468,009 $0
Q2 2022

May 14, 2024
SELL
$66.18 - $83.18 $2.22 Million - $2.79 Million
-33,536 Reduced 2.85%
1,144,990 $87 Million
Q2 2022

Aug 15, 2022
BUY
$66.18 - $83.18 $21.9 Million - $27.6 Million
331,530 Added 40.76%
1,144,990 $87 Million
Q1 2022

May 16, 2022
SELL
$66.02 - $79.71 $409,588 - $494,520
-6,204 Reduced 0.76%
813,460 $64.6 Million
Q4 2021

Feb 14, 2022
SELL
$63.34 - $74.11 $22.4 Million - $26.2 Million
-353,043 Reduced 30.1%
819,664 $60.2 Million
Q3 2021

Nov 10, 2021
BUY
$68.67 - $84.02 $80.5 Million - $98.5 Million
1,172,707 New
1,172,707 $80.7 Million

Others Institutions Holding INCY

# of Institutions
642
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email